Isoprinosine: lack of antiviral activity in experimental model infections.
D000605:Amino Alcohols / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002335:Carnivora; D002415:Cats; D004195:Disease Models, Animal; D004216:Distemper / Q000188:drug therapy; D004285:Dogs; D004338:Drug Combinations; D004686:Encephalomyocarditis virus; D005254:Feline Panleukopenia / Q000188:drug therapy; D005260:Female; D005761:Gastroenteritis, Transmissible, of Swine / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D007288:Inosine / Q000627:therapeutic use; D051379:Mice; D009705:Nucleosides / Q000627:therapeutic use*; D009976:Orthomyxoviridae Infections / Q000188:drug therapy; D011817:Rabbits; D011818:Rabies / Q000188:drug therapy; D018139:Simplexvirus; D013552:Swine; D014412:Tumor Virus Infections / Q000188:drug therapy; D014615:Vaccinia / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy*; D014780:Viruses / Q000187:drug effects
D000605:Amino Alcohols; D000998:Antiviral Agents; D001565:Benzoates; D004338:Drug Combinations; D009705:Nucleosides; D007288:Inosine